Antimicrobial Stewardship: A Commitment to Healthier People

Elanco's Long-Standing Commitment

As a company dedicated to the health and wellbeing of animals, Elanco is committed to increasing antibiotic stewardship and combatting antimicrobial resistance. Antimicrobial resistance (AMR) is a critical, complex issue and we’re working with leaders across human and animal health to develop long-term, responsible solutions.  For more than 15 years, Elanco has been focused on increasing responsible antibiotic use, reducing the need for antibiotics and replacing antibiotics with alternatives whenever possible.  

Antimicrobial stewardship has been a priority for Elanco for more than a decade. We have led industry transformation in this space and have made tangible progress to drive the responsible use of antibiotics. At the same time, we’ve focused on finding new solutions and alternatives to solve our most pressing healthcare concerns around antibiotic resistance.

Dr. S. Simjee, Chief Medical Officer

Through our pipeline, policies, and advocacy efforts, we seek to protect the benefits of antibiotics in human medicine, while responsibly protecting the health of farm animals and the safety of our food supply. Elanco has intentionally shifted our business away from shared-class antibiotics – those used in both humans and animals. We've removed growth promotion from nearly 100 product labels globally and removed over-the-counter use from nearly 70 product labels to require the oversight of a veterinarian. Most importantly, Elanco has focused on expanding access to animal-only antibiotics, which don’t create a threat to human resistance, and creating antibiotic alternatives, including vaccines, enzymes, probiotics and prebiotics. For example, Elanco’s work in vaccines, particularly salmonella, directly reduces exposure to pathogens in people, ultimately reducing the need for antibiotics in both animals and people.

By 2030, Elanco will seek to:

  • Invest more than $3.5B in innovation to pursue the discovery and development of products that improve the health and care of animals, including products that would reduce the need for medically important antibiotics.
  • Expand the availability of vaccines, nutritional health products, and diagnostics in underserved markets that currently rely on medically important antibiotics.
  • Increase access to innovation, knowledge, and partnerships for small-holder farmers by adapting the value-chain to ensure the responsible use of antibiotics.
  • Expand engagement with stakeholders, solicit concerns and expectations of responsible antibiotic use and the responsible care of antibiotics.

Our Antibiotic Stewardship Principals

Elanco is committed to continuing our antibiotic stewardship programs, visit our antibiotic stewardship principals for more details.

More Resources

You Might Be Interested in...

Get to know Elanco and our perspective on animal health by exploring more articles below.

two farmers in a barn looking at the cows with one farmer touching a cow

Products & Services

Discover our innovative solutions through our products and services that contribute toward healthier food animals and pets.

person holding chicken in front of bamboo

Our Programs & Initiatives

See how we advance our vision of food and companionship, enriching life through participation in programs and community projects.

two farmers in front of a field full of cows holding something and inspecting the item

Research & Development

Learn how we use industry expertise and data-driven insights to challenge and address animal health innovation.

Connect with Elanco

Country selector

Elanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2024 Elanco or its affiliates.